3.9. urinary biomarkers microbiome. interest role urinary biomarkers diagnosis lut dysfunction increased recent years. nerve growth factor (ngf), brain derived neurotrophic factor (bdnf), prostaglandin e2, adenosin triphosphate (atp) purinergic receptors (p2x) bladder tissue studied biomarkers oab. serum beta natriuretic peptide (bnp), urinary 6-sulfaoxymelatonin c-reactive protein (crp), melatonin, vasopressin levels studied relation nocturia. sui, urinary il 12-70, urinary (ungf) n-telopeptide type collagen (ntx) urinary microbiota studied. currently, studies investigating urinary biomarkers methodologically limited often due failing control confounding variables results conflicting . another area discovery role urinary microbiota identifying differentiating various types ui lut disease women. sr described studies showing differences types relative proportions bacteria lactobacillus, gardnerella, atopobium vaginae, among women different types ui compared healthy controls. urinary microbiota also shown differ depending womenâ€™s response anticholinergic treatment response . research needed place urine microbiota assessment clinical pathway women luts fully defined. information diagnostic efficacy biomarkers oab found section 4.1.3. 3.9.1. summary evidence recommendation urinary biomarkers summary evidencelethere insufficient evidence diagnostic accuracy validity urinary biomarkers lut disease women.3differences urinary microbiota found associated different types lut dysfunction women, including ui, different responses treatment.3 recommendationstrength ratingdo routinely use urinary biomarkers estimation urinary microbiota diagnosis management lut disease women.strong